A study funded by the National Institutes of Health (NIH) provides the clearest evidence to date to link severe chronic traumatic encephalopathy (CTE) to dementia risk.
Press Releases
Displaying 1 - 5 of 5
Friday, June 21, 2024
NIH-funded study shines light on disease mechanisms, pointing to possible therapeutic targets
Wednesday, January 31, 2024
Proteins could serve as biomarkers that improve diagnosis and guide the development of novel therapies
Monday, May 8, 2023
Scientists at the National Institutes of Health have identified new genetic risk factors for two types of non-Alzheimer’s dementia.
Monday, February 28, 2022
Researchers from two independent research teams have discovered how the mislocalization of a protein, known as TDP-43, alters the genetic instructions for UNC13A, providing a possible therapeutic target that could also have implications in treating amyotrophic lateral sclerosis (ALS), frontotemporal dementia (FTD), and other forms of dementia.